Share Name Share Symbol Market Type
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.66 -4.25% 14.88 13.50 15.47 15.39 14.28 15.17 6,297,694 04:00:03

Mylan, Pfizer Say Upjohn Deal Closing Delayed to 2nd Half

26/03/2020 11:40am

Dow Jones News

Historical Stock Chart

1 Month : From Feb 2020 to Mar 2020

Click Here for more Mylan NV Charts.

By Colin Kellaher


Mylan N.V. and Pfizer Inc. on Thursday said they now expect their planned deal to combine Pfizer's off-patent drugs business Upjohn with generic drugmaker Mylan to close in the second half of the year due the coronavirus pandemic.

The companies, which had expected the transaction to close in mid-2020, said the pandemic has resulted in delays in the regulatory review process.

The companies said Mylan will move its extraordinary general meeting of shareholders, which had been slated for April 27 to approve the transaction, to June 30, in conjunction with its annual general meeting.

Mylan and Pfizer said there are no other changes to the terms or plans regarding the transaction.


Write to Colin Kellaher at


(END) Dow Jones Newswires

March 26, 2020 07:25 ET (11:25 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.

1 Year Mylan NV Chart

1 Year Mylan NV Chart

1 Month Mylan NV Chart

1 Month Mylan NV Chart
ADVFN Advertorial
Your Recent History
Mylan NV
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20200329 09:09:32